Researchers at UC San Diego School of Medicine have pioneered MuSIC, a cutting-edge tool combining microscopy, biochemistry, and AI to map cellular contents with unprecedented precision. This pilot study, published in Nature, sheds light on disease mechanisms.
Many diseases stem from cellular malfunctions, like tumors driven by faulty gene-to-protein translation. To combat them effectively, scientists need a complete inventory of cellular components—but we're far from that goal today.
"If you imagine a cell, you're probably picturing the colorful diagram from your biology textbook, with mitochondria, endoplasmic reticulum, and nucleus. But is that the whole story? Definitely not," explains Dr. Trey Ideker, professor at UC San Diego School of Medicine.
Cells are far more structurally complex than previously thought, but much of this detail has remained elusive. Now, significant progress is underway.
By integrating advanced microscopy, biochemical methods, and artificial intelligence, UC San Diego researchers have advanced our understanding of human cells through Multi-Scale Integrated Cell (MuSIC) analysis, detailed in a recent Nature study.
Microscopes reveal organelles at the micron scale, like mitochondria, while biochemical techniques probe the nanometer level. AI in MuSIC bridges this gap, creating a unified view.
Applied to a human kidney cell line, MuSIC identified about 70 components, with half previously unknown. Many are RNA-binding proteins crucial for gene splicing, which controls protein production and gene activation.
Unlike traditional mapping, MuSIC doesn't fix components to specific locations yet, as their positions vary by cell type and condition.
This study focused on one cell type, but the team plans to expand to diverse cells and species. By comparing healthy and diseased cells, we could pinpoint molecular disease drivers.
